349 related articles for article (PubMed ID: 17289495)
21. Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopenia.
Lassila R; Antovic JP; Armstrong E; Baghaei F; Dalsgaard-Nielsen J; Hillarp A; Holme PA; Holmström M; Johnsson H; Joutsi-Korhonen L; Sandset PM
Semin Thromb Hemost; 2011 Apr; 37(3):328-36. PubMed ID: 21455867
[TBL] [Abstract][Full Text] [Related]
22. A case of heparin-induced thrombocytopenia with repeated episodes of acute lower extremity arterial thromboembolism during a short time.
Masumoto H; Shimamoto M; Yamazaki F; Nakai M; Fujita S; Itonaga T; Nomura R
Ann Thorac Cardiovasc Surg; 2007 Oct; 13(5):365-7. PubMed ID: 17954999
[TBL] [Abstract][Full Text] [Related]
23. [Bounderies of the authorization to market and the therapeutic impass].
Samama CM
Ann Fr Anesth Reanim; 2001 Jun; 20(6):507-8. PubMed ID: 11471497
[No Abstract] [Full Text] [Related]
24. Thrombosis during the use of the heparinoid Organon 10172 in a patient with heparin-induced thrombocytopenia.
Insler SR; Kraenzler EJ; Bartholomew JR; Kottke-Marchant K; Lytle B; Starr NJ
Anesthesiology; 1997 Feb; 86(2):495-8. PubMed ID: 9054269
[No Abstract] [Full Text] [Related]
25. [Thrombopenia induced by heparin: treatment with Org 10172. Tolerability and efficacy].
Tardy-Poncet B; Reynaud J; Tardy B; Mahul P; Mismetti P; Beraud AM; Rebaud MA; Bayon M; Guyotat D
Presse Med; 1996 May 4-11; 25(16):751-5. PubMed ID: 8692750
[TBL] [Abstract][Full Text] [Related]
26. Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass.
von Segesser LK; Mueller X; Marty B; Horisberger J; Corno A
Perfusion; 2001 Sep; 16(5):411-6. PubMed ID: 11565896
[TBL] [Abstract][Full Text] [Related]
27. [Heparin-induced thrombocytopenia].
Christoffersen C; Lethagen S; Gøtze JP
Ugeskr Laeger; 2009 Feb; 171(8):612-5. PubMed ID: 19284907
[TBL] [Abstract][Full Text] [Related]
28. Anticoagulation in patients with heparin-induced thrombocytopenia type II.
Harenberg J; Huhle G; Piazolo L; Wang LU; Heene DL
Semin Thromb Hemost; 1997; 23(2):189-96. PubMed ID: 9200346
[TBL] [Abstract][Full Text] [Related]
29. Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines.
Gurbuz AT; Elliott WG; Zia AA
Eur J Cardiothorac Surg; 2005 Jan; 27(1):138-49. PubMed ID: 15621486
[TBL] [Abstract][Full Text] [Related]
30. Heparin-induced thrombocytopenia: principles for early recognition and management.
Bartholomew JR; Begelman SM; Almahameed A
Cleve Clin J Med; 2005 Apr; 72 Suppl 1():S31-6. PubMed ID: 15853177
[TBL] [Abstract][Full Text] [Related]
31. Danaparoid for heparin-induced thrombocytopenia: an analysis of treatment failures.
Kodityal S; Manhas AH; Udden M; Rice L
Eur J Haematol; 2003 Aug; 71(2):109-13. PubMed ID: 12890149
[TBL] [Abstract][Full Text] [Related]
32. Eczematous plaques related to unfractionated and low-molecular-weight heparins: cross-reaction with danaparoid but not with desirudin.
Martin L; Machet L; Gironet N; Pouplard C; Gruel Y; Vaillant L
Contact Dermatitis; 2000 May; 42(5):295-6. PubMed ID: 10789857
[No Abstract] [Full Text] [Related]
33. Heparin-induced thrombocytopenia and its treatment.
Warkentin TE
J Thromb Thrombolysis; 2000 Jun; 9 Suppl 1():S29-35. PubMed ID: 10859582
[No Abstract] [Full Text] [Related]
34. [Delayed intracutaneous test reaction in heparin intolerance].
Wurpts G; Merk HF
Hautarzt; 2007 May; 58(5):394-6. PubMed ID: 17450341
[No Abstract] [Full Text] [Related]
35. [Anticoagulant].
Mitome J; Yamamoto H
Nihon Rinsho; 2004 May; 62 Suppl 5():368-73. PubMed ID: 15197947
[No Abstract] [Full Text] [Related]
36. The use of danaparoid to manage coagulopathy in a neurosurgical patient with heparin-induced thrombocytopenia type II and intracerebral haemorrhage.
Hertle DN; Hähnel S; Richter GM; Unterberg A; Sakowitz OW; Kiening KL
Br J Neurosurg; 2011 Feb; 25(1):117-9. PubMed ID: 20707682
[TBL] [Abstract][Full Text] [Related]
37. Additional anticoagulant strategies for managing heparin-induced thrombocytopenia.
Nawarskas JJ; Spinler SA
Am J Health Syst Pharm; 1996 Apr; 53(8):945. PubMed ID: 8728386
[No Abstract] [Full Text] [Related]
38. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
Jeske WP; Walenga JM
Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
[TBL] [Abstract][Full Text] [Related]
39. Argatroban and bivalirudin compared to unfractionated heparin in preventing thrombus formation on mechanical heart valves. Results of an in-vitro study.
Maegdefessel L; Linde T; Michel T; Hamilton K; Steinseifer U; Friedrich I; Schubert S; Hauroeder B; Raaz U; Buerke M; Werdan K; Schlitt A
Thromb Haemost; 2009 Jun; 101(6):1163-9. PubMed ID: 19492162
[TBL] [Abstract][Full Text] [Related]
40. [Two surgical case reports showing atypical heparin-induced thrombocytopenia].
Höhnke C; Haas S
Chirurg; 2007 Feb; 78(2):138, 140-1. PubMed ID: 17252251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
